The persistence of a low viral load during the first twelve weeks of hepatitis C therapy is associated with an increased of relapse after the completion of treatment, investigators report in the December 1st edition of Clinical Infectious Diseases.
Even with complete viral suppression, a high baseline viral load also increased the risk of relapse. The German study involved patients with hepatitis C mono-infection.
Read more.....
0 comments:
Post a Comment